IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression

Xue,Dan; Yang,Ping; Wei,Qiongying; Li,Xiaoping; Lin,Lan; Lin,Tingyan

doi:10.3892/ijmm.2019.4354

IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression

Authors:
- Dan Xue
- Ping Yang
- Qiongying Wei
- Xiaoping Li
- Lan Lin
- Tingyan Lin
View Affiliations

Affiliations: Department of Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China, Department of Respiratory Medicine, People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350001, P.R. China
Published online on: September 26, 2019 https://doi.org/10.3892/ijmm.2019.4354
Pages: 1697-1706
Copyright: © Xue et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lung cancer is considered to be one of the world's deadliest diseases, with non‑small cell lung cancer (NSCLC) accounting for 85% of all lung cancer cases. The present study aimed to investigate the role and underlying mechanisms of interleukin‑21 (IL‑21), and its receptor IL‑21R, in NSCLC. Lung tissues and blood samples of NSCLC were used to measure IL‑21, IL‑21R and programmed death 1 ligand 1 (PD‑L1) expression using ELISA, western blot and immunohistochemistry analyses. Following treatment with different doses of IL‑21, the proliferation, invasion and migration of human NSCLC cell line A549 was evaluated using a cell counting kit‑8, colony formation, Transwell and scratch wound healing assays, respectively. Additionally, IL‑21R and PD‑L1 expression in A549 cells was detected using western blot analysis and immunofluorescence. IL‑21R silencing was subsequently used to investigate its effects in cell proliferation, invasion and migration. PD‑L1, IL‑1β and tumor necrosis factor α (TNF‑α) expression were measured. Finally, Wnt/β‑catenin signaling expression was evaluated using western blot analysis following treatment with IL‑21. Cells were then treated with lithium chloride (LiCl), which is an agonist of Wnt/β‑catenin signaling, and the levels of PD‑L1, IL‑1β and TNF‑α were detected. The results revealed that IL‑21 and IL‑21R expression in the lung tissues and blood samples of patients with NSCLC were decreased, while PD‑L1 expression was increased, compared with normal tissues or healthy controls. Treatment of A549 cells with IL‑21 upregulated IL‑21R expression, downregulated PD‑L1 and inhibited cell growth and metastasis in a dose‑dependent manner. Following IL‑21R silencing, the effects of IL‑21 treatment were reversed, suggesting that IL‑21 acted on A549 cells through binding to IL‑21R. In addition, the results demonstrated that IL‑21 treatment reduced the expression levels of proteins associated with the Wnt/β‑catenin signaling, whereas activation of Wnt/β‑catenin signaling with the LiCl agonist upregulated PD‑L1, IL‑1β and TNF‑α expression. In conclusion, the IL‑21/IL‑21R axis reduced the growth and invasion of NSCLC cells via inhibiting Wnt/β‑catenin signaling and PD‑L1 expression. The present results may provide a novel molecular target for NSCLC diagnosis and therapy.

View Figures

View References

1	Hao H, Zhou Z, Li S, Maquilan G, Folkert MR, Iyengar P, Westover KD, Albuquerque K, Liu F, Choy H, et al: Shell feature: A new radiomics descriptor for predicting distant failure after radiotherapy in non-small cell lung cancer and cervix cancer. Phys Med Biol. 63:0950072018. View Article : Google Scholar : PubMed/NCBI
2	Shaw AT and Engelman JA: Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med 3. 70:2537–2539. 2014.
3	Shroff GS, Viswanathan C, Carter BW, Benveniste MF, Truong MT and Sabloff BS: Staging lung cancer: Metastasis. Radiol Clin North Am. 56:411–418. 2018. View Article : Google Scholar : PubMed/NCBI
4	Legras A, Pécuchet N, Imbeaud S, Pallier K, Didelot A, Roussel H, Gibault L, Fabre E, Le Pimpec-Barthes F, Laurent-Puig P and Blons H: Epithelial-to-mesenchymal transition and microRNAs in lung cancer. Cancers (Basel). 9. pp. E1012017, View Article : Google Scholar
5	Pawlak K, Gabryel P, Kujawska A, Kasprzyk M, Piwkowski C, Kuffel B and Dyszkiewicz W: Long-term results of surgical treatment of non-small cell lung cancer in patients over 75 years of age. Kardiochir Torakochirurgia Pol. 15:65–71. 2018.PubMed/NCBI
6	Xu X, Chen D, Ye B, Zhong F and Chen G: Curcumin induces the apoptosis of non-small cell lung cancer cells through a calcium signaling pathway. Int J Mol Med. 35:1610–1616. 2015. View Article : Google Scholar : PubMed/NCBI
7	Monteleone I, Pallone F and Monteleone G: Interleukin-23 and Th17 cells in the control of gut inflammation. Mediators Inflamm. 2009.297645:2009.
8	Fu ZQ, Zhou Q, Zhu S and Liu W: Anti-tumor mechanism of IL-21 used alone and in combination with 5-fluorouracil in vitro on human gastric cancer cells. J Biol Regul Homeost Agents. 32:619–625. 2018.PubMed/NCBI
9	Chen C, Liu X and Ren Y: Interleukin 21 treatment in a murine model as a novel potential cytokine immunotherapy for colon cancer. Adv Clin Exp Med. 27:583–589. 2018. View Article : Google Scholar : PubMed/NCBI
10	Zhang Y, Wang J, Wu D, Li M, Zhao F, Ren M, Cai Y and Dou J: IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer. Onco Targets Ther. 11:2037–2050. 2018. View Article : Google Scholar :
11	Liu L, Shi F, Li S, Liu X, Wei L, Zhang J, Ju X and Yu J: IL-21 polymorphisms rs907715 and rs2221903 are associated with decreased non-small cell lung cancer susceptibility. Int J Clin Exp Med. 8:19460–19465. 2015.
12	Qiu L, Yu Q, Zhou Y, Zheng S, Tao J, Jiang Q and Yuan G: Functionally impaired follicular helper T cells induce regulatory B cells and CD14⁺ human leukocyte antigen-DR^- cell differentiation in non-small cell lung cancer. Cancer Sci. 109:3751–3761. 2018. View Article : Google Scholar : PubMed/NCBI
13	Kaltenmeier C, Gawanbacht A, Beyer T, Lindner S, Trzaska T, van der Merwe JA, Härter G, Grüner B, Fabricius D, Lotfi R, et al: CD4⁺ T cell-derived IL-21 and deprivation of CD40 signaling favor the in vivo development of granzyme B-expressing regulatory B cells in HIV patients. J Immunol. 194:3768–3777. 2015. View Article : Google Scholar : PubMed/NCBI
14	Wang JY, Wang X, Wang XJ, Zheng BZ, Wang Y, Wang X and Liang B: Curcumin inhibits the growth via Wnt/β-catenin pathway in non-small-cell lung cancer cells. Eur Rev Med Pharmacol Sci. 22:7492–7499. 2018.PubMed/NCBI
15	Wang XH, Cui YX, Wang ZM and Liu J: Down-regulation of FOXR2 inhibits non-small cell lung cancer cell proliferation and invasion through the Wnt/β-catenin signaling pathway. Biochem Biophys Res Commun. 500:229–235. 2018. View Article : Google Scholar : PubMed/NCBI
16	Spranger S, Bao R and Gajewski TF: Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. Nature. 523:231–235. 2015. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:pp. 402–408. 2001, View Article : Google Scholar
18	Santegoets SJ, Turksma AW, Powell DJ Jr, Hooijberg E and de Gruijl TD: IL-21 in cancer immunotherapy: At the right place at the right time = Oncoimmunology. 2:pp. e245222013, PubMed/NCBI
19	Croce M, Rigo V and Ferrini S: IL-21: A pleiotropic cytokine with potential applications in oncology. J Immunol Res. 2015.696578:2015.
20	Moroz A, Eppolito C, Li Q, Tao J, Clegg CH and Shrikant PA: IL-21 enhances and sustains CD8⁺ T cell responses to achieve durable tumor immunity: Comparative evaluation of IL-2, IL-15, and IL-21. J Immunol. 173:900–909. 2004. View Article : Google Scholar : PubMed/NCBI
21	Spolski R and Leonard WJ: Interleukin-21: A double-edged sword with therapeutic potential. Nat Rev Drug Discov. 13:379–395. 2014. View Article : Google Scholar : PubMed/NCBI
22	Shao J, Xu Q, Su S, Meng F, Zou Z, Chen F, Du J, Qian X and Liu B: Engineered cells for costimulatory enhancement combined with IL-21 enhance the generation of PD-1-disrupted CTLs for adoptive immunotherapy. Cell Immunol. 320:38–45. 2017. View Article : Google Scholar : PubMed/NCBI
23	Qu QX, Xie F, Huang Q and Zhang XG: Membranous and cytoplasmic expression of PD-L1 in ovarian cancer cells. Cell Physiol Biochem. 43:1893–1906. 2017. View Article : Google Scholar : PubMed/NCBI
24	Tang Y, Fang W, Zhang Y, Hong S, Kang S, Yan Y, Chen N, Zhan J, He X, Qin T, et al: The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs. Oncotarget. 6:14209–14219. 2015. View Article : Google Scholar : PubMed/NCBI
25	Mu CY, Huang JA, Chen Y, Chen C and Zhang XG: High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. Med Oncol. 28:682–688. 2011. View Article : Google Scholar
26	Pang L, Han S, Jiao Y, Jiang S, He X and Li P: Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation. Int J Oncol. 51:25–38. 2017. View Article : Google Scholar : PubMed/NCBI
27	Li T, Ren J, Ma J, Wu J, Zhang R, Yuan H and Han X: LINC00702/miR-4652-3p/ZEB1 axis promotes the progression of malignant meningioma through activating Wnt/β-catenin pathway. Biomed Pharmacother. 113:1087182019. View Article : Google Scholar
28	Jing JC, Feng Z, Chen ZH, Ji BN, Hong J, Tang N, Yu JL and Wang SY: KDM4B promotes gastric cancer metastasis by regulating miR-125b-mediated activation of Wnt signaling. J Cell Biochem. 2018.
29	Yang Y, Liu L, Cai J, Wu J, Guan H, Zhu X, Yuan J and Li M: DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt/β-catenin signaling. Biochem Biophys Res Commun. 450:899–905. 2014. View Article : Google Scholar : PubMed/NCBI